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Abstract
Background: Degeneration of intraepidermal nerve fibers (IENF) is a hallmark of small fiber neuropathy of different
etiology, whose clinical picture is dominated by neuropathic pain. It is unknown if critical illness can affect IENF.
Methods: We enrolled 14 adult neurocritical care patients with prolonged intensive care unit (ICU) stay and artificial
ventilation (≥ 3 days), and no previous history or risk factors for neuromuscular disease. All patients underwent
neurological examination including evaluation of consciousness, sensory functions, muscle strength, nerve
conduction study and needle electromyography, autonomic dysfunction using the finger wrinkling test, and skin
biopsy for quantification of IENF and sweat gland innervation density during ICU stay and at follow-up visit.
Development of infection, sepsis and multiple organ failure was recorded throughout the ICU stay.
Results: Of the 14 patients recruited, 13 (93%) had infections, sepsis or multiple organ failure. All had severe and
non-length dependent loss of IENF. Sweat gland innervation was reduced in all except one patient. Of the 7 patients
available for follow-up visit, three complained of diffuse sensory loss and burning pain, and another three showed
clinical dysautonomia.
Conclusions: Small fiber pathology can develop in the acute phase of critical illness and may explain chronic
sensory impairment and pain in neurocritical care survivors. Its impact on long term disability warrants further studies
involving also non-neurologic critical care patients.
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Introduction
Survivors of critical illness may suffer from prolonged
disability [1]. Several causes contribute to this so-called “post-
intensive care syndrome”, which is defined as new or
worsening impairment in physical, cognitive, or mental health
status arising after critical illness and persisting beyond acute
care hospitalization [2]. Critical illness polyneuropathy affects
sensory and motor fibers innervating limb and respiratory
muscles [3] and is a prominent cause of persisting physical
disability [4], leading to difficulty in weaning the patient from
mechanical ventilation and flaccid tetraparesis [5]. Sensory
nerve impairment is usually reported after intensive care unit
(ICU) discharge [5,6]. Stocking and glove sensory loss, feeling
of cool extremities, numbness, tingling, and neuropathic pain
symptoms including hyperalgesia and burning have been
described at long-term follow-up of ICU survivors [5,6]. In some
patients, pain can be extremely intense, precluding effective
rehabilitation [7]. In a recent series of 16 patients with acute
respiratory distress syndrome evaluated at 6 to 24 months after
ICU discharge, 6 patients reported variable combinations of
pain, numbness, tingling, diffuse weakness, cool extremities,
and impaired exercise ability [6] in the absence of
abnormalities at nerve conduction study (NCS). The lack of
correlation between clinical and electrophysiological findings
suggested a small fiber neuropathy [6]; however, skin biopsy,
which is required to document the degeneration of
intraepidermal nerve fibers (IENF) and to define the diagnosis
[8], was not performed and therefore the hypothesis could not
be confirmed.
Degeneration of IENF has been described in small fiber
neuropathy (SFN) of different etiology [9,10] and in other
neuropathies dominated by neuropathic pain, including those
with predominantly large fiber involvement such as Guillain-
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Barré syndrome [11-14] and chronic demyelinating
polyradiculoneuropathy [15]. Most recently, small fiber
dysfunction has been also described in fibromyalgia [16]. The
diagnosis of SFN is confirmed by the quantification of IENF
density at the distal site of the leg, based on age and gender-
adjusted normative reference values [17]. When a more diffuse
and non-length depended process is suspected, such as in
sensory neuronopathies [18], or in acute or chronic
demyelinating neuropathies [15,19], the IENF density should
be examined also at a proximal site of the body, such as the
thigh or the trunk.
We hypothesized that critically ill patients may suffer from
small nerve fiber pathology as part of the generalized
inflammatory process leading to multiple organ dysfunctions
and failures. To address this hypothesis, we prospectively
monitorized organ function and performed skin biopsy during
the ICU stay, and evaluated the survived patients at follow-up
with focused neurological examination. Our results provide the
first-ever evidence that critical illness causes also small nerve
fiber degeneration since the early phases of the disease.
Materials and Methods
Critically ill neurologic patients admitted to the Neurocritical
Care Unit of the University of Brescia at the Spedali Civili of
Brescia, Italy, from September 1, 2011 to May 1, 2012 were
consecutively recruited. Inclusion criteria were age ≥18 years,
ICU stay ≥ 3 days, and need of either invasive or non-invasive
ventilatory support. Criteria for exclusion were ascertained after
discussion with patient’s family physician and family members,
and after careful investigation of the clinical charts of previous
hospital admissions. Exclusion criteria included the following:
any previously known neuromuscular disease or condition at
risk for peripheral neuropathy, such as diabetes, systemic
diseases with renal, hepatic or thyroid dysfunction, alcohol
abuse, HIV or hepatitis C infection, hematological diseases or
monoclonal gammopathy of uncertain significance, vitamin B12
deficiency, connective tissue diseases (e.g. Sjögren
syndrome), malignancies, previous or current treatment with
neurotoxic drugs (e.g. antineoplastic or anti-arrhythmic drugs).
We also excluded patients with chronic pain, those in terminal
conditions and those in whom skin biopsy could not be taken or
electrophysiological investigations of peripheral nerves and
muscles were not feasible (e.g. coagulation disorders, plasters,
limb amputation, limb edema, etc.) [20].
Ethics statement
The study was approved by the Ethics Committee of the
University of Brescia at Spedali Civili (CRitical Illness
Neuropathy of Epidermal fibers - CRINE study doc n.371/gt).
Because all patients had brain injury and altered
consciousness at ICU admission, the Ethics Committee
permitted to use waived consent. In fact, the definition of the
legal representative, or surrogate, of adult temporarily
incapacitated ICU patients is absent in Italy [21]. Detailed
written information was provided to the family members about
the study protocol, the need for and safety of minimally
invasive skin biopsy and the need of follow-up visits. At follow-
up, written informed consent was obtained from the patients if
they had regained their mental competency. All clinical
investigations were conducted according to the principles
expressed in the Declaration of Helsinki.
General, neurological, and electrophysiological
assessment
During the ICU stay, patients were followed daily for the
development of sepsis or multiple organ failure (MOF). Sepsis
was defined according to current recommendations as the
presence of both infection and systemic inflammatory response
[22]. MOF was diagnosed as the evidence of two or more
organ failures according to the sequential organ failure
assessment score [23].
As critically ill patients often develop acute sensory-motor
axonal polyneuropathy and/or myopathy, we performed nerve
conduction studies (NCS) and needle electromyography
(EMG). We adopted currently recommended criteria to
diagnose critical illness polyneuropathy (CIP) and critical illness
myopathy (CIM) [3] using conventional techniques. Manual
muscle strength testing was not possible during the ICU stay
due to the altered consciousness of patients. Hence, we
defined CIP and CIM as “probable” based on previously
proposed criteria [3].
At follow-up, all patients underwent neurological examination
including evaluation of consciousness, sensory functions, and
muscle strength when permitted by the patient clinical
conditions. Signs suggestive of autonomic dysfunction (e.g.
abnormal sweating, lacrimation and/or salivation;
gastrointestinal, bladder, and sexual disorders; orthostatic
hypotension) were recorded. The finger wrinkling test was
recorded after immersion of the right hand in a bucket filled
with water at 40 °C and used to investigate sympathetic
peripheral dysautonomia [24]. The degree of skin wrinkling at
the fingertip was assessed at baseline and after 5, 15, and 30
minutes, and graded using a semi-quantitative 5-point clinical
scale. We scored 0 in case of absent wrinkling, 1 when the skin
was not completely smooth, 2 when two or less lines of
wrinkling were seen, 3 when three or more lines of wrinkling
were seen, and 4 when wrinkling completely distorted the pulp
of the fingertip. The scores from 0 to 2 were considered
abnormal (e.g. peripheral dysautonomia), whereas scores ≥3
were considered normal [25]. Severity of spontaneous and
evoked pain (tactile allodynia and hyperalgesia) was graded
using the 11-point Likert numerical rating score (NRS).
The modified Rankin Scale (mRS) was used to categorize
the outcome as follow: mRS; 1= no symptoms; 2 or 3=
moderate disability, able to walk but unable to perform all
activities independently; 4= moderate-to-severe disability,
unable to walk independently; 5= severe disability, bed-bound;
6= dead.
Skin biopsy
Skin biopsies were performed with a minimally invasive
technique [8] as soon as the general condition stabilized (e.g.
when there was no evidence of intracranial hypertension;
coagulation disorders; hemodynamic instability requiring
inotropic support; respiratory failure requiring mandatory
Small Nerve Fiber Pathology
PLOS ONE | www.plosone.org 2 September 2013 | Volume 8 | Issue 9 | e75696
mechanical ventilation; kidney insufficiency requiring dialysis;
fever or sepsis). Biopsies were taken using a 3-mm disposable
punch, after local anesthesia with 2% lidocaine under sterile
technique, at the distal site of the leg (10 cm above the lateral
malleolus within the territory of the sural nerve) and at the
proximal site on the thigh (20 cm below the iliac spine).
Specimens were immediately fixed for 24 hours at 4°C,
cryoprotected, and shipped to the Skin Biopsy Laboratory at
the “Carlo Besta” Neurological Institute of Milan, Italy, to be
processed. Three sections randomly chosen from each sample
were immunoassayed with polyclonal anti-protein gene product
(PGP) 9.5 antibodies (Biogenesis, Poole, Dorset, UK; 1:1000)
using the free-floating protocol for bright-field
immunohistochemistry previously described [26]. The linear
density of IENF was calculated according to current guidelines
[17]. Densities from patients’ distal leg biopsy samples were
compared with age- and gender-adjusted normative values
[17], whereas those from the proximal thigh were compared
with archive normative values [9]. Sweat gland innervation was
assessed using a semi-quantitative approach comparing the
density of PGP9.5-positive fibers around ducts with archive
biopsy sections from healthy subjects. Sweat gland were
considered completely or partially denervated when no or only
sparse PGP 9.5-positive fibers, respectively, were
recognizable.
Data presentation
Data were reported as means and standard deviation (SD)
when normally distributed, and median with 25 to 75% quartiles
(interquartile range, IQR) when not normally distributed.
Results
During the study period, 246 patients were excluded
because the ICU stay was less than 3 days (158 patients), or
patients had diabetes (41 patients), malignancy (19 patients),
alcohol abuse (7 patients), renal insufficiency (4 patients), liver
cirrhosis (4 patients), pre-existing neuromuscular disorders (3
patients), hepatitis C infection (2 patients), patients were in
terminal condition (7 patients) or skin biopsy was not feasible
(1 patients). Fourteen consecutive patients (5.7%) were
eventually recruited.
Demographic characteristics, admission diagnoses, NCS,
EMG, and skin biopsy findings are detailed in Table 1. Median
duration of mechanical ventilation was 12 days (IQR 8-15).
Median ICU stay was 17 days (IQR 11-18). Thirteen patients
developed sepsis during the ICU stay, predominantly related to
respiratory, urinary, and bloodstream infections. Only one did
not have proven infection despite persistent fever.
NCS study and EMG were performed on median ICU day 8
(IQR 7-14 days) and revealed CIM in 8 patients, CIP in 4
patients, and normal findings in 2 patients.
Skin biopsies were obtained on median ICU day 22 (IQR
18-24 days). All patients showed a severe and non-length
dependent degeneration of IENF with densities below normal
values at both distal leg and proximal thigh (table 1). Epidermal
and dermal nerves showed diffuse degenerative changes with
fragmented and weak staining. Sweat glands were severely
denervated in all except one patient with CIM (Figure 1). There
were no complications associated with skin biopsies.
Two patients died after ICU discharge. At follow-up, 2
patients regained full functional independence, 1 patient had
mild disability, 4 patients had moderate-to-severe disability,
and 5 patients had severe disability (table 2). Seven patients
(no. 2, 5, 7, 8, 11, 12, 14) were available for follow-up
examination and three of them complained of sensory loss and
burning pain (no. 2, 8 and 12). Pain was diffuse, and in one
patient (no. 2) it was so severe to interfere with effective
physical rehabilitation. Intriguingly, all these 3 patients had
acute myopathy with no evidence of large fiber sensory
neuropathy at NCS. Their sensory symptoms likely reflected a
small fiber neuropathy as diagnosed by skin biopsy.
Clinical dysautonomia was observed in 3 patients, of whom 1
(no. 9) also had abnormal finger wrinkling test (table 2). The
only patient with normal density of sweat gland nerve fibers at
skin biopsy (no. 6) did not show any sign of systemic,
cardiovascular, and peripheral dysautonomia at clinical
evaluation and finger wrinkling test.
Discussion
We report the first-ever observation that critical illness can be
associated with a non-length dependent degeneration of
somatic and autonomic small nerve fibers. This complication
developed in critically ill patients with severe infection, sepsis
or MOF, and prolonged mechanical ventilation and ICU stay. In
association with the degeneration of IENF, patients showed
also electrophysiological evidence of acute axonopathy of large
nerve fibers and acute myopathy, confirming that
neuromuscular alterations of critical illness complicate the
clinical course of the most severely ill patients and are not
isolated events, but rather are an integral part of the process
leading to multiple organ dysfunctions and failures [3].
IENF degeneration has been described in several chronic
conditions, such as diabetic neuropathy [27,28], but also in
acute inflammatory neuropathies, such as Guillain-Barré
syndrome [11-14]. Patients with SFN typically present with
neuropathic pain and reduced thermal and pain sensation but
with normal strength, proprioceptive sensation, and deep
tendon reflexes reflecting normal large nerve fiber functions
[9,10,29,30]. At skin biopsy, reduced IENF density is typically
demonstrated [30]. In our series, we found a non-length
dependent degeneration of somatic IENF in all the patients,
suggesting that critical illness likely affects dorsal root ganglion
(DRG) neurons. Patients available for neurological examination
at follow-up complained of diffuse pain and thermal and
nociceptive sensory loss, a pattern typical of sensory
neuronopathies [18]. DRG neurons are surrounded by
fenestrated capillaries instead of a tight barrier and are
therefore exposed to circulating neurotoxic factors from the
bloodstream. Circulating mediators such as endotoxin, other
proinflammatory agents (tumor necrosis factor-a, serotonin,
and histamine) or neurotoxic factors are probably released
during sepsis or systemic inflammatory response syndrome,
and have been proposed in the pathogenesis of CIP, but their
role remains controversial because CIP can occur in the
Small Nerve Fiber Pathology
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Figure 1.  Skin biopsy.  Bright field immunohistochemical studies (polyclonal anti-protein gene product 9.5 antibody; Ultraclone,
Wellow, Isle of Wight, UK) in sections of skin biopsy taken at the proximal thigh (A) and distal site of the leg (B) with a sweat gland
(C) in patient no. 7, and at the proximal thigh (D) and distal site of the leg (E) with a sweat gland (F) in a healthy subject.
Arrows indicate intra-epidermal nerve fibers and arrowheads indicate dermal nerve bundles. The patient, with normal nerve
conduction study findings and myopathy at needle electromyography, showed a severe depletion of intra-epidermal nerve fibers and
a severe reduction in the density of dermal nerve bundles, whose staining was fragmented and weaker due to axonal degeneration.
Sweat gland innervation was also markedly reduced. Original magnification 40x. Bar is 50 µm in all images.
doi: 10.1371/journal.pone.0075696.g001
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absence of an identifiable circulating mediator [31]. Future
studies should investigate these candidate neurotoxic factors
for their effects on the tiny nerve fibers of the skin.
Our analyses of skin biopsies were aimed at describing
morphometric and morphologic features of epidermal and
dermal nerves, and did not include immunohistochemical
assays of cytokines or adhesion molecule expression, which
might provide clue to the underlying pathogenetic mechanisms
of IENF degeneration. Increased production of pro-
inflammatory cytokines has a key role in promoting the organ
dysfunction during the early phase of critical illness [32], and
may also increase the microvascular nerve permeability
leading to formation of endoneurial and axon disruption [3,33].
Since all our patients developed infections and sepsis during
the ICU stay, we hypothesize that the degeneration of IENF
was caused by the same mechanisms leading to axonal
degeneration of large nerve fibers and multiple organ
dysfunction. This hypothesis is further supported by the strict
inclusion criteria adopted, which allowed us to exclude patients
at risk for neuropathy before ICU admission. In addition, we
performed all skin biopsies during the ICU stay over a relatively
short period of time in order to detect potential risk factors with
high accuracy. Future studies should evaluate if skin
accumulation of inflammatory cytokines or increased
expression of adhesion molecules might play a role in IENF
degeneration during critical illness.
Neuropathic pain, defined as pain caused by a disease or a
lesion of the somatosensory nervous system [34], was
observed in 3 patients who showed thermal and nociceptive
sensory loss and burning pain associated with IENF loss. This
Table 2. Patients’ neurological findings at follow-up visit.
PatientSensory signs Motor signs Dysautonomic signs
Finger
wrinkling test
Follow-up (days
after ICU discharge) GCS
Outcome
mRS
No.      Eye-Motor-Verbal  
1 NA NA NA NA 6 months / 6
2
Sensory loss, severe paroxysmal
pain (NRS 9/10) and continuous
burning pain (NRS 3/10) in lower
limbs; dynamic mechanic allodynia
Spastic paraparesis None 3 13 months 15 4
3 NA NA NA NA 9 months / 6
4
Grimacing and limb movements after
pain stimulation of lower limbs; no
reaction after upper limb stimulation
Spontaneous limb
movements, pyramidal
signs.
None 3 9 months 4-5-1 (globalaphasia) 5
5 None Left hemiparesis None 4 9 months 15 3
6 Not assessable Spastic tetraplegia None 3 8 months 4-3-1 5
7 None None None 3 10 months 15 1
8 Sensory loss, burning pain (NRS5/10)
Spastic paraplegia, upper
limb weakness None NA 10 months 4-6-2 5
9 Not assessable Spastic tetraplegia
Orthostatic
hypotension,
tachycardia, abnormal
sweating, clammy skin
1 10 months 4-2-1 (VS) 5
10 Not assessable Flaccid tetraplegia
Orthostatic
hypotension,
tachycardia, abnormal
sweating, clammy skin
NA 10 months 4-1-1 (MCS) 5
11 None None None NA 10 months 15 1
12
Light touch, pinprick, and vibratory
sensory loss with stocking-glove
distribution; burning pain at distal
lower limbs (NRS 4/10)
Reduced foot dorsiflexion None 3 9 months 15 3
13 Grimacing after pain stimulation ofupper and lower limbs
Upper limb extension and
lower limb flexion after
painful stimulation
Tachycardia, abnormal
sweating NA 8 months 4-2-1 (MCS) 5
14 None Right hemiparesis None 4 8 months 15 4
Finger wrinkling test: scores from 0 to 2 indicate abnormal skin wrinkling; score of 3 or 4 indicate normal skin wrinkling. GCS, Glasgow Coma Scale. mRS, modified Rankin
Scale: 0= no symptoms; 1= no significant disability despite symptoms; 2, 3= mild or moderate disability; 4= moderate-to-severe disability; 5= severe disability; 6=dead. VS,
vegetative state. MCS, minimally conscious state.
doi: 10.1371/journal.pone.0075696.t002
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picture was likely caused by the exclusive degeneration of
small nerve fibers, because NCS were normal, therefore
excluding CIP or other large fiber neuropathies. Besides
degeneration of the somatic IENF, all except one patient
showed a profound denervation of skin sweat glands indicating
autonomic peripheral involvement. Autonomic dysfunctions
were evident in 3 patients, one of whom also had abnormal
finger wrinkling test. However, the impact of these
abnormalities on patients’ outcome could not be assessed due
to severe neurologic conditions. This result confirms previous
report of autonomic dysfunction with abnormal cardiac R-R
variation and sympathetic skin response in ICU patients with
critical illness polyneuropathy or septic encephalopathy [35].
One major limitation of our study is the small sample of
patients with no control group and the fact that accurate
neurological evaluation of the sensory system at follow-up was
possible only in a subset of patients. Future studies should
involve larger samples of non-neurologic critical care patients.
In future follow-up studies, serial skin biopsies could also be
offered to patients to evaluate the natural progression of the
disease and the effect of potential treatments [36]. Finally,
inclusion of patients without sepsis and MOF would help to
confirm if IENF degeneration is part of the process leading to
MOF.
Our study could contribute in addressing some issues
regarding the long-term outcome of ICU survivors. In particular,
chronic pain is common and probably involves multiple
pathogenetic mechanisms [6,37,38]. Our findings suggest that
the degeneration of somatic and autonomic small nerve fibers
is a frequent complication of critical illness and explained the
persisting sensory deficits and neuropathic pain observed in
some survivors. In such cases, skin biopsy is a safe, almost
painless, and cheap technique that can be offered to patients
for evaluating small nerve fibers.
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